Announcements Trials
Browse Landscape

Status

Completed 3

Sponsor Class

INDUSTRY 3

Study Type

Observational 3

Sponsor

Cancer Type

Classical hematology 3

Conditions

Anemia 116Neoplasms 77Anemia, Refractory, with Excess of Blasts 32Myelodysplastic Syndromes 31Leukemia, Myeloid, Acute 28Venous Thromboembolism 25Thrombocytopenia 24Leukemia 22Breast Neoplasms 22Febrile Neutropenia 21Neutropenia 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Multiple Myeloma 15Lymphoma 14Hematologic Neoplasms 14Anemia, Sickle Cell 14Ovarian Neoplasms 12Myeloproliferative Disorders 10Leukemia, Lymphocytic, Chronic, B-Cell 10Fanconi Anemia, Complementation Group D1 10Venous Thrombosis 9Primary Myelofibrosis 9Lung Neoplasms 9Leukemia, Myelomonocytic, Chronic 9Prostatic Neoplasms 8Lymphoma, Non-Hodgkin 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Hodgkin Disease 8Pulmonary Embolism 7Hemophilia A 7

Interventions

Rivaroxaban 3Heparin, Low-Molecular-Weight 3acarboxyprothrombin 1N(4)-oleylcytosine arabinoside 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Treatment of Venous Thromboembolism in Cancer Patients × Classical hematology × Clear all
NCT04979780 2024-10-31

OSCAR-US

Bayer

Completed
3,708 enrolled
Classical hematology

Treatment of Venous Thromboembolism in Cancer Patients

NCT05150938 2023-12-18

A Study to Gather Information About Rivaroxaban in Patients in Sweden With Cancer Who Also Have Thrombosis (OSCAR-SE)

Bayer

Completed
5,737 enrolled
Classical hematology

Treatment of Venous Thromboembolism in Cancer Patients

NCT05112666 2023-04-03

A Study to Gather Information About Rivaroxaban in Patients in the United Kingdom Who Have Cancer and Thrombosis (OSCAR-UK)

Bayer

Completed
2,601 enrolled
Classical hematology

Treatment of Venous Thromboembolism in Cancer Patients

Data powered by HemOnc (CC BY 4.0) Colophon âš¡